Clinical study of a single-use, point-of-care molecular diagnostic device for the detection ofneisseria gonorrheaoe (NG), trichomoniasis vaginalis (TV), and chlamydia trachomatis (CT) utilizing…
Ended Awarded Last action
- Contract number
- HHSN27200010
- Awardee
-
Social & Scientific Systems, Inc. UEI XKMBEM2BTLK3 Part of DLH Holdings Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,960,082
Award facts
- Contract value 100% obligated
- $4,960,081.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$4,780 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $608,795 | |
| Supplemental Agreement for work within scope | $1,046,425 | |
| Original award | $3,309,642 |
About this award
This is a $4,960,081.66 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The contract is for a clinical study of a single-use, point-of-care molecular diagnostic device for the detection of sexually transmitted infections including Neisseria gonorrhoeae, Trichomonas vaginalis, and Chlamydia trachomatis using vaginally collected swabs. The contract has no set-aside designation. Key subcontractors include the University of Mississippi Medical Center, the Philadelphia Department of Public Health, the University of California, and the Johns Hopkins University, among others. This contract supports NIAID's mission to conduct and support research to understand, treat, and prevent infectious diseases.
Description
Clinical study of a single-use, point-of-care molecular diagnostic device for the detection ofneisseria gonorrheaoe (NG), trichomoniasis vaginalis (TV), and chlamydia trachomatis (CT) utilizing vaginally collected swabs.
Quick answers
Who was awarded contract HHSN27200010?
HHSN27200010 was awarded to Social & Scientific Systems, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 13, 2017.
How much is contract HHSN27200010 worth?
The government has obligated $4,960,082 on HHSN27200010.
Is contract HHSN27200010 an order under another contract?
Yes. HHSN27200010 is a delivery order under HHSN272201300014I, an indefinite delivery contract.
Was contract HHSN27200010 competed?
The extent of competition for HHSN27200010 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award